|
HY-100006A-25mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-5mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-50mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006B-1mg
|
MedChemexpress LLC
|
MRT68921 (hydrochloride) [CAS 2070014-87-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-100007-100mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100007-250mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100008-10mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100008-100mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100008-5mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100008-50mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100009-10mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100009-100mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100009-5mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100009-50mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100011-10mg
|
MedChemexpress LLC
|
SR-3029 [CAS 1454585-06-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100011-100mg
|
MedChemexpress LLC
|
SR-3029 [CAS 1454585-06-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100011-2mg
|
MedChemexpress LLC
|
SR-3029 [CAS 1454585-06-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100011-25mg
|
MedChemexpress LLC
|
SR-3029 [CAS 1454585-06-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100011-5mg
|
MedChemexpress LLC
|
SR-3029 [CAS 1454585-06-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100011-50mg
|
MedChemexpress LLC
|
SR-3029 [CAS 1454585-06-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100012-10mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100012-100mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100012-25mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100012-5mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100012-50mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
